 "Anuh Pharma surges on receiving WHO prequalification for Sulfadoxine")
Anuh Pharma has rallied 9% to Rs 339 on the BSE in early morning trade after the pharmaceutical company said that it has received World Health Organization (WHO) prequalification for the product Sulfadoxine.
The company last week received Good Manufacturing Practice (GMP) certificate from COFEPRIS (Health Authority of Mexico) for two products - Chloramphenicol and Chloramphenicol Palmitate.
Anuh Pharma is one of the largest manufacturers of Macrolides and Anti-TB products in India, besides being a major player in Anti-bacterials, Anti-malarial, Antihypertension and Corticosteroids.
At 09:34 am, the stock was up 6% at Rs 332 on the BSE. About 24,000 equity shares have already changed hands on the counter so far against an average 29,000 shares were traded daily in past two weeks on the BSE.
The company last week received Good Manufacturing Practice (GMP) certificate from COFEPRIS (Health Authority of Mexico) for two products - Chloramphenicol and Chloramphenicol Palmitate.
Anuh Pharma is one of the largest manufacturers of Macrolides and Anti-TB products in India, besides being a major player in Anti-bacterials, Anti-malarial, Antihypertension and Corticosteroids.
At 09:34 am, the stock was up 6% at Rs 332 on the BSE. About 24,000 equity shares have already changed hands on the counter so far against an average 29,000 shares were traded daily in past two weeks on the BSE.